Coalition for Epidemic Preparedness Innovations: Innovative technologies to improve vaccine thermostability (Expression of Interest)

Expressions of Interest may be submitted at any time until final deadline and will be reviewed on a quarterly basis.

Aim: to improve vaccine thermostability for use in outbreaks of known viruses as well as novel or previously unrecognised viruses. These can be novel technologies or adaptations of existing (proven) technologies that show measurable improvements in terms of increased thermostability of any vaccine platform to extend vaccine access. The CfP is divided into two focus areas:

Focus area 1: seeks to improve the thermostability of vaccine platforms that currently require freezing (in particular RNA-based platforms) to a minimum target that allows them to be distributed via the established 2-8°C cold chain.

Focus area 2: aims to improve thermostability of any vaccine platform to a preferred target of 40°C that allows the last stage of the supply chain to occur without cold chain equipment.

The total budget for thermostability innovations is $17.5M over a five-year period, with the aim to start funding 3 to 5 projects in 2022

https://cepi.net/get_involved/cfps/?learn-more-7099=2